Your browser doesn't support javascript.
loading
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
Green, Anders; Ramey, Dena Rosen; Emneus, Martha; Iachina, Maria; Stavem, Knut; Bolin, Kristian; McNally, Richard; Busch-Sørensen, Michael; Willenheimer, Ronnie; Egstrup, Kenneth; Kesäniemi, Y Antero; Ray, Simon; Basta, Nermine; Kent, Christi; Pedersen, Terje R.
Afiliación
  • Green A; Institute of Applied Economics and Health Research, Copenhagen, Denmark; Odense Patient Data Explorative Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. Electronic address: agreen@health.sdu.dk.
  • Ramey DR; Merck & Company, Inc., Whitehouse Station, New Jersey.
  • Emneus M; Institute of Applied Economics and Health Research, Copenhagen, Denmark.
  • Iachina M; Institute of Applied Economics and Health Research, Copenhagen, Denmark.
  • Stavem K; Institute of Clinical Medicine Akershus University Hospital, University of Oslo, Oslo, Norway; Department of Pulmonary Medicine, Medical Division, Akershus University Hospital, Oslo, Norway; Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
  • Bolin K; Centre for Health Economics and the Department of Economics and Statistics, University of Gothenburg, Gothenburg, Sweden.
  • McNally R; Institute of Health and Society, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Busch-Sørensen M; Merck & Company, Inc., Whitehouse Station, New Jersey.
  • Willenheimer R; Department of Cardiology, Lund University, University Hospital, Malmö, Sweden.
  • Egstrup K; Medical Division, Odense University Hospital Svendborg Hospital, Svendborg, Denmark.
  • Kesäniemi YA; Institute of Clinical Medicine, Department of Medicine, University of Oulu and Medical Research Center, Oulu University Hospital, Oulu, Finland.
  • Ray S; Department of Cardiology, Northwest Heart Centre, University Hospitals of South Manchester, Manchester, United Kingdom.
  • Basta N; Institute of Health and Society, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Kent C; Merck & Company, Inc., Whitehouse Station, New Jersey.
  • Pedersen TR; Center of Preventive Medicine, Oslo University Hospital Ullevål, and Faculty of Medicine, University of Oslo, Oslo, Norway.
Am J Cardiol ; 114(10): 1518-22, 2014 Nov 15.
Article en En | MEDLINE | ID: mdl-25267716
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Estenosis de la Válvula Aórtica / Azetidinas / Sistema de Registros / Medición de Riesgo / Simvastatina / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Am J Cardiol Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Estenosis de la Válvula Aórtica / Azetidinas / Sistema de Registros / Medición de Riesgo / Simvastatina / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Am J Cardiol Año: 2014 Tipo del documento: Article